Physician profile
Omar Khan
NPI 1972898856
$4,889.90
in general payments reported to CMS, 2019-2025
43 companies · $673 in 2025
The $673 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $392 · 2021: $936 · 2022: $955 · 2023: $948 · 2024: $738 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,899 · Travel and Lodging: $262 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,899.42 |
| Travel and Lodging | $262.28 |
| Education | $197.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $893.09 | 2019-2025 | Xtandi, Myrbetriq |
| Myovant Sciences INC. | $277.28 | 2021-2022 | |
| Procept Biorobotics Corporation | $262.28 | 2024 | Aquabeam System |
| Astrazeneca Pharmaceuticals LP | $261.19 | 2022-2025 | Lynparza |
| Endo Pharmaceuticals INC. | $246.31 | 2019-2023 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $244.56 | 2019-2023 | Erleada |
| Histosonics, INC. | $222.22 | 2025 | |
| Medtronic, INC. | $220.16 | 2023-2024 | Interstim |
| Rochester Medical Corporation | $213.52 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $171.08 | 2023-2025 | Orgovyx, Gemtesa |
| Intuitive Surgical, INC. | $163.32 | 2021 | |
| Antares Pharma, INC. | $157.36 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Blue Earth Diagnostics | $139.99 | 2019-2022 | |
| Pfizer INC. | $132.20 | 2019-2025 | |
| C. R. Bard, INC. & Subsidiaries | $119.53 | 2023-2024 | Bard Urinary Drainage Bag |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.